Daniel J. Weisdorf

University of Minnesota — United States

Medicine · Health Sciences

126h-index75.6kcitations1.3kworks3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(719), Acute Lymphoblastic Leukemia research(307), Acute Myeloid Leukemia Research(292), Immune Cell Function and Interaction(166), Chronic Myeloid Leukemia Treatments(120)

Publications1.3k total

Supplementary Table S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S2 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S3 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S5 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S6 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S4 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Supplementary Figure S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
2025Open Access
Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning
Blood·2025Open Access
Total body irradiation and cigarette smoking interact to increase the risk of lung cancer in blood or marrow transplant (BMT) survivors – a BMTSS report
Blood·2025Open Access
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy
Clinical Transplantation·2025Open Access
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Annual household income and chronic pulmonary conditions in long-term survivors of blood or marrow transplantation: a BMTSS report
BMC Pulmonary Medicine·2025Open Access
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation
Bone Marrow Transplantation·2025Open Access
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
UNC Libraries·2025Open Access
Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report
Bone Marrow Transplantation·2025
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study
Transplantation·2025· 1 citedOpen Access
Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]
UNC Libraries·2025Open Access
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
UNC Libraries·2025Open Access
A Risk Adaptive Approach at Reduced Intensity Conditioning (RIC) and Transplantation of HLA-Haploidentical Hematopoietic Cells Using Fludarabine, Melphalan, Cyclophosphamide, and Total Body Irradiation (Flu/Mel/Cy/TBI) for Elderly or Infirm.
Transplantation and Cellular Therapy·2025
page 1 of 66Next →

Frequent Co-authors

Jeffrey S. Miller(15), Todd E. DeFor(15), Bruce R. Blazar(14), John E. Wagner(13), Mary M. Horowitz(12), Stephanie J. Lee(9), Michael R. Verneris(9), Sarah Cooley(8), Corey Cutler(7), Philip B. McGlave(7), Juliet N. Barker(7), Mukta Arora(6), Steven Z. Pavletic(6), Stella M. Davies(6), Joseph H. Antin(6), Mary E.D. Flowers(5), Steven M. Devine(5), Margaret L. MacMillan(5), Christopher Bredeson(5), Robert Peter Gale(5)